Header Logo

Connection

WOLFGANG WINKELMAYER to Kidney Failure, Chronic

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Kidney Failure, Chronic.
WOLFGANG WINKELMAYER
Connection Strength
26.594
Kidney Failure, Chronic
  1. Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 01 17; 329(3):205-206.
    View in: PubMed
    Score: 0.489
  2. The dialysis care-policy issue: Guest Editors' introductory remarks. Semin Dial. 2020 01; 33(1):4.
    View in: PubMed
    Score: 0.396
  3. Trends in the Medical Complexity and Outcomes of Medicare-insured Patients Undergoing Kidney Transplant in the Years 1998-2014. Transplantation. 2019 11; 103(11):2413-2422.
    View in: PubMed
    Score: 0.391
  4. Selective Serotonin Reuptake Inhibitor Use and Hip Fracture Risk Among Patients on Hemodialysis. Am J Kidney Dis. 2020 03; 75(3):351-360.
    View in: PubMed
    Score: 0.390
  5. Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis. Clin J Am Soc Nephrol. 2019 07 05; 14(7):1029-1038.
    View in: PubMed
    Score: 0.381
  6. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. Eur Heart J. 2019 03 14; 40(11):887-898.
    View in: PubMed
    Score: 0.374
  7. Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. Am J Kidney Dis. 2019 03; 73(3):324-331.
    View in: PubMed
    Score: 0.366
  8. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.365
  9. Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation. Semin Nephrol. 2018 11; 38(6):618-628.
    View in: PubMed
    Score: 0.365
  10. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541.
    View in: PubMed
    Score: 0.363
  11. Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 2018 09 01; 33(9):1590-1597.
    View in: PubMed
    Score: 0.361
  12. The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
    View in: PubMed
    Score: 0.356
  13. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
    View in: PubMed
    Score: 0.346
  14. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States. Transplantation. 2017 10; 101(10):2636-2647.
    View in: PubMed
    Score: 0.339
  15. A Case for More Frequent, Not Just Earlier, Nephrology Care of Patients Approaching ESRD? Am J Kidney Dis. 2017 08; 70(2):155-157.
    View in: PubMed
    Score: 0.335
  16. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus. J Am Heart Assoc. 2017 Jun 07; 6(6).
    View in: PubMed
    Score: 0.331
  17. Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis. Nephrol Dial Transplant. 2017 May 01; 32(5):862-869.
    View in: PubMed
    Score: 0.329
  18. Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145.
    View in: PubMed
    Score: 0.329
  19. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex. Am J Kidney Dis. 2017 Jun; 69(6):771-779.
    View in: PubMed
    Score: 0.322
  20. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. J Nephrol. 2017 Apr; 30(2):281-288.
    View in: PubMed
    Score: 0.312
  21. Kidney Transplantation Outcomes across GN Subtypes in the United States. J Am Soc Nephrol. 2017 02; 28(2):632-644.
    View in: PubMed
    Score: 0.312
  22. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis. J Am Coll Cardiol. 2016 Mar 29; 67(12):1459-1469.
    View in: PubMed
    Score: 0.305
  23. Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data. BMC Nephrol. 2016 Feb 09; 17:16.
    View in: PubMed
    Score: 0.302
  24. Differences in Initial Hemodialysis Vascular Access Use Among Glomerulonephritis Subtypes in the United States. Am J Kidney Dis. 2016 Apr; 67(4):638-47.
    View in: PubMed
    Score: 0.300
  25. Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease. BMC Nephrol. 2015 Dec 09; 16:204.
    View in: PubMed
    Score: 0.299
  26. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA. Nephrol Dial Transplant. 2016 Feb; 31(2):290-8.
    View in: PubMed
    Score: 0.298
  27. Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. Nephrol Dial Transplant. 2015 Dec; 30(12):2068-75.
    View in: PubMed
    Score: 0.293
  28. Treated and Untreated Kidney Failure: Quantifying an Outcome. Am J Kidney Dis. 2015 Aug; 66(2):187-9.
    View in: PubMed
    Score: 0.291
  29. Timing of Dialysis Initiation-Do Health Care Setting or Provider Incentives Matter? Clin J Am Soc Nephrol. 2015 Aug 07; 10(8):1321-3.
    View in: PubMed
    Score: 0.291
  30. Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant. 2015 Oct; 30(10):1734-40.
    View in: PubMed
    Score: 0.290
  31. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. Am J Kidney Dis. 2015 Oct; 66(4):677-88.
    View in: PubMed
    Score: 0.290
  32. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
    View in: PubMed
    Score: 0.289
  33. Comparative health services research across populations: the unused opportunities in big data. Kidney Int. 2015 Jun; 87(6):1094-6.
    View in: PubMed
    Score: 0.288
  34. Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc. 2014 Oct 21; 3(5):e001356.
    View in: PubMed
    Score: 0.276
  35. Commentary on 'the DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients': the calm before the 2016 storm? Am J Kidney Dis. 2014 May; 63(5):854-8.
    View in: PubMed
    Score: 0.267
  36. State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol. 2014 Jun; 25(6):1321-9.
    View in: PubMed
    Score: 0.265
  37. Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States. Am J Transplant. 2014 Apr; 14(4):943-951.
    View in: PubMed
    Score: 0.264
  38. Commentary on 'The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle': iron(y) abounds 2 years later. Am J Kidney Dis. 2013 Dec; 62(6):1217-20.
    View in: PubMed
    Score: 0.260
  39. Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. Am J Transplant. 2013 Jun; 13(6):1566-75.
    View in: PubMed
    Score: 0.251
  40. Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. Clin J Am Soc Nephrol. 2013 Aug; 8(8):1336-42.
    View in: PubMed
    Score: 0.250
  41. Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System. Am J Kidney Dis. 2013 Aug; 62(2):312-21.
    View in: PubMed
    Score: 0.249
  42. Assessments of causal effects--theoretically sound, practically unattainable, and clinically not so relevant. Clin J Am Soc Nephrol. 2013 Apr; 8(4):520-2.
    View in: PubMed
    Score: 0.247
  43. More evidence on an abominable pairing: atrial fibrillation and kidney disease. Circulation. 2013 Feb 05; 127(5):560-2.
    View in: PubMed
    Score: 0.245
  44. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol. 2012 Dec; 23(12):2042-9.
    View in: PubMed
    Score: 0.242
  45. Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks? Curr Opin Nephrol Hypertens. 2012 Nov; 21(6):600-6.
    View in: PubMed
    Score: 0.241
  46. Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013 Mar-Apr; 33(2):155-66.
    View in: PubMed
    Score: 0.240
  47. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012 Nov 06; 126(19):2293-301.
    View in: PubMed
    Score: 0.240
  48. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis. Am J Kidney Dis. 2012 Sep; 60(3):473-86.
    View in: PubMed
    Score: 0.233
  49. Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 2012 May-Jun; 25(3):341-53.
    View in: PubMed
    Score: 0.233
  50. Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol. 2012 Jun; 23(6):1078-85.
    View in: PubMed
    Score: 0.232
  51. Commentary on 'The DOPPS practice monitor for US dialysis care: trends through April 2011': no surprises yet. Am J Kidney Dis. 2012 Feb; 59(2):312-4.
    View in: PubMed
    Score: 0.229
  52. Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol. 2012 Mar; 23(3):495-506.
    View in: PubMed
    Score: 0.228
  53. Altitude and the risk of cardiovascular events in incident US dialysis patients. Nephrol Dial Transplant. 2012 Jun; 27(6):2411-7.
    View in: PubMed
    Score: 0.228
  54. Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. Clin J Am Soc Nephrol. 2012 Feb; 7(2):289-96.
    View in: PubMed
    Score: 0.226
  55. Air pollution and coronary risk in kidney transplant recipients. Am J Kidney Dis. 2011 Oct; 58(4):506-7.
    View in: PubMed
    Score: 0.223
  56. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2662-8.
    View in: PubMed
    Score: 0.223
  57. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011 Aug 08; 171(15):1371-8.
    View in: PubMed
    Score: 0.221
  58. Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J. 2011 Aug; 162(2):324-30.
    View in: PubMed
    Score: 0.220
  59. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011 Sep; 58(3):409-17.
    View in: PubMed
    Score: 0.219
  60. The effect of altitude change on anemia treatment response in hemodialysis patients. Am J Epidemiol. 2011 Apr 01; 173(7):768-77.
    View in: PubMed
    Score: 0.214
  61. The 2011 ESRD prospective payment system: an uncontrolled experiment. Am J Kidney Dis. 2011 Apr; 57(4):542-6.
    View in: PubMed
    Score: 0.214
  62. Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease care. Blood Purif. 2011; 31(1-3):66-9.
    View in: PubMed
    Score: 0.213
  63. Off-label use of phosphate binders in non-dialysis-dependent CKD. Am J Kidney Dis. 2010 Nov; 56(5):813-6.
    View in: PubMed
    Score: 0.210
  64. Confusion about the appropriate use of erythropoiesis-stimulating agents in patients undergoing maintenance dialysis. Semin Dial. 2010 Sep-Oct; 23(5):486-91.
    View in: PubMed
    Score: 0.207
  65. Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA. 2010 Mar 03; 303(9):857-64.
    View in: PubMed
    Score: 0.200
  66. Lessons from geographic variations in predialysis nephrology care. J Am Soc Nephrol. 2009 May; 20(5):930-2.
    View in: PubMed
    Score: 0.189
  67. Altitude and all-cause mortality in incident dialysis patients. JAMA. 2009 Feb 04; 301(5):508-12.
    View in: PubMed
    Score: 0.186
  68. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1415-22.
    View in: PubMed
    Score: 0.179
  69. The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol. 2008 Jul; 19(7):1389-95.
    View in: PubMed
    Score: 0.175
  70. Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice. Am J Kidney Dis. 2008 Mar; 51(3):362-5.
    View in: PubMed
    Score: 0.174
  71. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005 Jan; 16(1):255-60.
    View in: PubMed
    Score: 0.139
  72. Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities. Am J Kidney Dis. 2025 Feb; 85(2):226-235.e1.
    View in: PubMed
    Score: 0.138
  73. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004 May; 15(5):1347-52.
    View in: PubMed
    Score: 0.134
  74. A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 07; 106(1):145-153.
    View in: PubMed
    Score: 0.133
  75. The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. Kidney Int. 2003 May; 63(5):1836-42.
    View in: PubMed
    Score: 0.125
  76. US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2023 03; 81(3 Suppl1):A8-A11.
    View in: PubMed
    Score: 0.123
  77. Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 05; 103(5):842-858.
    View in: PubMed
    Score: 0.123
  78. Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. JAMA. 2022 11 08; 328(18):1837-1848.
    View in: PubMed
    Score: 0.121
  79. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. Circulation. 2022 12 06; 146(23):1735-1745.
    View in: PubMed
    Score: 0.121
  80. Association of Bradycardia and Asystole Episodes with Dialytic Parameters: An Analysis of the Monitoring in Dialysis (MiD) Study. Kidney360. 2022 11 24; 3(11):1871-1880.
    View in: PubMed
    Score: 0.120
  81. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol. 2002 Sep; 13(9):2353-62.
    View in: PubMed
    Score: 0.119
  82. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making. 2002 Sep-Oct; 22(5):417-30.
    View in: PubMed
    Score: 0.119
  83. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
    View in: PubMed
    Score: 0.119
  84. Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med. 2002 Aug; 17(8):588-95.
    View in: PubMed
    Score: 0.118
  85. US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2022 04; 79(4 Suppl 1):A8-A12.
    View in: PubMed
    Score: 0.116
  86. Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 06; 33(6):1063-1072.
    View in: PubMed
    Score: 0.115
  87. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. 2022 01 01; 7(1):75-83.
    View in: PubMed
    Score: 0.114
  88. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001 Oct; 60(4):1547-54.
    View in: PubMed
    Score: 0.112
  89. Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
    View in: PubMed
    Score: 0.112
  90. US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2021 04; 77(4 Suppl 1):A7-A8.
    View in: PubMed
    Score: 0.108
  91. The impact of COVID-19 on kidney transplantation and the kidney transplant recipient - One year into the pandemic. Transpl Int. 2021 04; 34(4):612-621.
    View in: PubMed
    Score: 0.107
  92. Intradialytic Hypotension and Newly Recognized Peripheral Artery Disease in Patients Receiving Hemodialysis. Am J Kidney Dis. 2021 05; 77(5):730-738.
    View in: PubMed
    Score: 0.106
  93. Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. J Am Heart Assoc. 2020 07 07; 9(13):e015969.
    View in: PubMed
    Score: 0.102
  94. Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 05; 97(5):861-876.
    View in: PubMed
    Score: 0.100
  95. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.100
  96. The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration. J Am Soc Nephrol. 2019 05; 30(5):890-903.
    View in: PubMed
    Score: 0.094
  97. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 07; 96(1):37-47.
    View in: PubMed
    Score: 0.094
  98. Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. J Am Soc Nephrol. 2019 02; 30(2):346-353.
    View in: PubMed
    Score: 0.093
  99. Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208.
    View in: PubMed
    Score: 0.092
  100. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.092
  101. Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
    View in: PubMed
    Score: 0.091
  102. Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Intern Med. 2018 10 01; 178(10):1358-1367.
    View in: PubMed
    Score: 0.091
  103. The Relationship between Intradialytic Hypotension and Hospitalized Mesenteric Ischemia: A Case-Control Study. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1517-1525.
    View in: PubMed
    Score: 0.091
  104. Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Atrial Fibrillation. Clin J Am Soc Nephrol. 2018 09 07; 13(9):1423-1425.
    View in: PubMed
    Score: 0.090
  105. Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
    View in: PubMed
    Score: 0.090
  106. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.089
  107. Cardiovascular Outcomes Reported in Hemodialysis Trials. J Am Coll Cardiol. 2018 06 19; 71(24):2802-2810.
    View in: PubMed
    Score: 0.089
  108. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis. 2018 10; 72(4):620-622.
    View in: PubMed
    Score: 0.088
  109. Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review. Am J Kidney Dis. 2018 07; 72(1):62-74.
    View in: PubMed
    Score: 0.087
  110. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
    View in: PubMed
    Score: 0.086
  111. Hospitalizations and Nursing Facility Stays During the Transition from CKD to ESRD on Dialysis: An Observational Study. J Gen Intern Med. 2017 Nov; 32(11):1220-1227.
    View in: PubMed
    Score: 0.084
  112. Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
    View in: PubMed
    Score: 0.081
  113. Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017 Feb; 69(2):266-277.
    View in: PubMed
    Score: 0.080
  114. Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop. Am J Kidney Dis. 2017 Jan; 69(1):97-107.
    View in: PubMed
    Score: 0.078
  115. Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis. Clin J Am Soc Nephrol. 2016 08 08; 11(8):1401-1412.
    View in: PubMed
    Score: 0.078
  116. Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
    View in: PubMed
    Score: 0.077
  117. Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis. Arthritis Care Res (Hoboken). 2015 Oct; 67(10):1453-62.
    View in: PubMed
    Score: 0.074
  118. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. Am J Kidney Dis. 2015 Jul; 66(1):106-13.
    View in: PubMed
    Score: 0.072
  119. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis. Am J Kidney Dis. 2015 Jul; 66(1):69-74.
    View in: PubMed
    Score: 0.070
  120. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
    View in: PubMed
    Score: 0.070
  121. Adiposity patterns and the risk for ESRD in postmenopausal women. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):241-50.
    View in: PubMed
    Score: 0.070
  122. Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7.
    View in: PubMed
    Score: 0.070
  123. Heparin use in hemodialysis patients following gastrointestinal bleeding. Am J Nephrol. 2014; 40(4):300-7.
    View in: PubMed
    Score: 0.069
  124. Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med. 2014 May; 174(5):699-707.
    View in: PubMed
    Score: 0.067
  125. Earlier- versus later-start peritoneal dialysis: not a moment too soon? Am J Kidney Dis. 2014 May; 63(5):741-4.
    View in: PubMed
    Score: 0.067
  126. Prognostic stratification in older adults commencing dialysis. J Gerontol A Biol Sci Med Sci. 2014 Aug; 69(8):1033-9.
    View in: PubMed
    Score: 0.066
  127. Coronary artery bypass graft type and outcomes in maintenance dialysis. J Cardiovasc Surg (Torino). 2015 Jun; 56(3):463-71.
    View in: PubMed
    Score: 0.065
  128. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2149-57.
    View in: PubMed
    Score: 0.064
  129. Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2213-20.
    View in: PubMed
    Score: 0.064
  130. Multivessel coronary revascularization and outcomes in kidney transplant recipients. Transpl Int. 2013 Nov; 26(11):1080-7.
    View in: PubMed
    Score: 0.064
  131. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013 Jun; 24(7):1151-8.
    View in: PubMed
    Score: 0.063
  132. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
    View in: PubMed
    Score: 0.062
  133. Predialyis nephrology care of older individuals approaching end-stage renal disease. Semin Dial. 2012 Nov-Dec; 25(6):628-32.
    View in: PubMed
    Score: 0.060
  134. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.
    View in: PubMed
    Score: 0.057
  135. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum. 2011 Jul; 63(7):1988-97.
    View in: PubMed
    Score: 0.055
  136. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011 Jun; 63(6):1681-8.
    View in: PubMed
    Score: 0.055
  137. Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population. Nephrol Dial Transplant. 2012 Jan; 27(1):429-34.
    View in: PubMed
    Score: 0.054
  138. The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5.
    View in: PubMed
    Score: 0.053
  139. Late referral to paediatric renal failure service impairs access to pre-emptive kidney transplantation in children. Arch Dis Child. 2010 Aug; 95(8):634-8.
    View in: PubMed
    Score: 0.051
  140. Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials. Transplantation. 2009 Dec 27; 88(12):1377-85.
    View in: PubMed
    Score: 0.049
  141. Chronic on acute renal failure: long-term implications of severe acute kidney injury. JAMA. 2009 Sep 16; 302(11):1227-9.
    View in: PubMed
    Score: 0.048
  142. Educational level as a determinant of access to and outcomes after kidney transplantation in the United States. Am J Kidney Dis. 2008 May; 51(5):811-8.
    View in: PubMed
    Score: 0.044
  143. No associations between prolactin concentrations and response to erythropoiesis-stimulating agents in hemodialysis patients. Am J Nephrol. 2007; 27(4):390-6.
    View in: PubMed
    Score: 0.042
  144. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients. Arch Intern Med. 2007 Apr 23; 167(8):840-6.
    View in: PubMed
    Score: 0.041
  145. Early erythropoietin therapy is associated with improved growth in children with chronic kidney disease. Pediatr Nephrol. 2007 Aug; 22(8):1189-93.
    View in: PubMed
    Score: 0.041
  146. Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes. Diabetes Care. 2006 Oct; 29(10):2210-7.
    View in: PubMed
    Score: 0.039
  147. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006 Mar; 17(3):889-99.
    View in: PubMed
    Score: 0.038
  148. Trends in Kidney Allograft Failure Among First-Time Transplant Recipients in the United States. Am J Kidney Dis. 2025 Mar; 85(3):273-283.e1.
    View in: PubMed
    Score: 0.035
  149. Regarding impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis. Kidney Int. 2004 Oct; 66(4):1712; author reply 1712-3.
    View in: PubMed
    Score: 0.034
  150. A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int. 2004 Sep; 66(3):1239-47.
    View in: PubMed
    Score: 0.034
  151. Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis. 2004 May; 174(1):43-8.
    View in: PubMed
    Score: 0.033
  152. Prescription and Dispensation of QT-Prolonging Medications in Individuals Receiving Hemodialysis. JAMA Netw Open. 2024 04 01; 7(4):e248732.
    View in: PubMed
    Score: 0.033
  153. Market Competition and Anemia Management in the United States Following Dialysis Payment Reform. Med Care. 2023 Nov 01; 61(11):787-795.
    View in: PubMed
    Score: 0.032
  154. Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 09; 104(3):441-454.
    View in: PubMed
    Score: 0.031
  155. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002 Sep 23; 162(17):2002-6.
    View in: PubMed
    Score: 0.030
  156. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002 Jul; 55(7):711-6.
    View in: PubMed
    Score: 0.029
  157. Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
    View in: PubMed
    Score: 0.028
  158. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 03 03; 77(3):948-959.
    View in: PubMed
    Score: 0.027
  159. Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease. Expert Opin Investig Drugs. 2000 Nov; 9(11):2637-51.
    View in: PubMed
    Score: 0.026
  160. Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Am J Kidney Dis. 2020 08; 76(2):157-160.
    View in: PubMed
    Score: 0.026
  161. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J. 2018 06 21; 39(24):2314-2325.
    View in: PubMed
    Score: 0.022
  162. Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):536-545.
    View in: PubMed
    Score: 0.020
  163. Phosphate Binders: The Evidence Gap Persists. Am J Kidney Dis. 2016 11; 68(5):667-670.
    View in: PubMed
    Score: 0.020
  164. Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related?Quality of Life in Patients Receiving?Hemodialysis. Am J Kidney Dis. 2016 Feb; 67(2):271-82.
    View in: PubMed
    Score: 0.019
  165. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
    View in: PubMed
    Score: 0.017
  166. The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med. 2013 Jun; 126(6):541.e1-541.e14.
    View in: PubMed
    Score: 0.016
  167. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000 Jun; 11(6):1106-1116.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.